EPCAM and pancreatic neoplasm: SOX2 knockdown in pancreatic cancer cells leads to an inhibition of cell growth, while SOX2 transfection promotes cell entry into S-phase and proliferation, and it also increases the expression levels of CSC pancreatic ALDH1, ESA, and CD44 markers [14].